All vancomycin articles
-
NewsNew weapon against the super tough C diff bacteria shows promise
A researcher has demonstrated that a newer generation tetracycline antibiotic, Omadacycline, may be a promising tool in combating the resilient bacteria Clostridioides difficile (C diff), which causes an infection often picked up in hospitals.
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsSpread of AMR bacteria linked to patient hand contamination and antibiotic use in nursing homes
Nursing home residents have an increasing diversity in the level of care required and this has coincided with an increase in the spread of drug resistant bacteria within these settings.
-
NewsScientists track the bacteria behind life-threatening sepsis in premature babies
Researchers who teamed up with two Neonatal Intensive Care Units (NICUs) have found that transmission of sepsis-causing Staphylococcus strains between babies within NICUs was likely.
-
NewsStaph mechanism for resistance to last resort drug is uncovered
New research has revealed the mechanism of transcriptional regulation via S-nitrosylation for resistance to last resort drug vancomycin in Staphylococcus aureus.
-
NewsInter-species interactions may stymie antibiotics
A new study suggests that between-species interactions within the gut microbiome may impact the efficacy of antibiotics aimed at treating C. difficile infections.
-
NewsNew shape-shifting antibiotics could fight deadly infections
Scientists have created a new weapon against these drug-resistant superbugs—an antibiotic that can shape-shift by rearranging its atoms.
-
NewsBlocked cell wall formation stops bacterial cell division
Researchers using high-performance microscopes to observe the effect of different antibiotics on Staphylococcus aureus have clarified how exactly different antibiotics block cell division within a few minutes.
-
NewsScientists develop novel combination therapy for treating vancomycin-resistant bacterial infections
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin.
